Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Change in Account Payables of $592000.0 for Q1 2026, up 238.29% on a YoY basis from $175000.0 in Q1 2025, and up 226.77% sequentially from -$467000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Change in Account Payables data on file, last reported at $592000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 238.29% year-over-year to $592000.0; the trailing twelve-month figure through Mar 2026 stood at -$611000.0 (up 4.83% YoY), and the FY2025 full-year result was -$1.0 million, down 711.9% from the prior year.
- Change in Account Payables improved to $592000.0 in Q1 2026, from -$467000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q3 2024 to a low of -$1.0 million in Q2 2024.
- A 4-year average of -$41800.0 and a median of -$170000.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables sank 470.67% in 2024 and soared 238.29% in 2026, its largest moves.
- Tracing CAMP's Change in Account Payables over 4 years: stood at -$150000.0 in 2023, then slumped by 470.67% to -$856000.0 in 2024, then surged by 45.44% to -$467000.0 in 2025, then surged by 226.77% to $592000.0 in 2026.
- Business Quant data shows CAMP's Change in Account Payables at $592000.0 in Q1 2026, -$467000.0 in Q4 2025, and -$546000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | 592,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 592,000.00 |
| Mar 31, 2026 | 592,000.00 |
| Dec 31, 2025 | -467,000.00 |
| Dec 31, 2025 | -467,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Jun 30, 2025 | -190,000.00 |
| Jun 30, 2025 | -190,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Dec 31, 2024 | -856,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | 985,000.00 |
| Mar 31, 2024 | 985,000.00 |
| Dec 31, 2023 | -150,000.00 |
| Dec 31, 2023 | -150,000.00 |